Nathan Connell: Bleeding Risk Is Not Limited to Delivery
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article published in Haemophilia Journal, co-authored by him and his colleagues, adding:
“Just published in Haemophilia Journal in conjunction with the World Federation of Hemophilia 2026 Congress in Kuala Lumpur, Malaysia: ‘Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders.’
Women and girls with inherited bleeding disorders have too often been under-recognized, under-diagnosed, and under-served.
This review highlights that bleeding risk is not limited to delivery.
It spans the reproductive lifespan, from heavy menstrual bleeding and iron deficiency, to fertility treatment, prenatal diagnosis, pregnancy planning, neuraxial anesthesia decisions, mode of delivery, and both primary and secondary postpartum hemorrhage.
A central message of the paper is that care must be proactive, multidisciplinary, and individualized.
For many patients, better outcomes depend on earlier recognition of bleeding symptoms, coordinated care across hematology, obstetrics, gynecology, anesthesia, and genetics, and thoughtful delivery planning well before labor.
The review also underscores how advances in preconception counseling, prenatal testing, and carrier evaluation are reshaping reproductive choice and risk assessment.
This is also a call to move beyond the historical framing of women only as ‘carriers’ and toward a model that recognizes their own bleeding phenotype, health risks, and need for lifelong care.
Grateful to my coauthors Joanna Davies, Rezan Abdul-Kadir, and Zane Kaplan for their partnership on this work.”
Title: Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders
Authors: Nathan T. Connell, Joanna Davies, Rezan Abdul-Kadir, Zane Kaplan
Other posts featuring Nathan Connell on Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic